Terms ending in 2029
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,598,199 | Octahydropentalene Compounds as Chemokine Receptor Antagonists In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,217,155 | Metabolites and Derivatives of Ambrisentan In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,648,084 | Selective Substituted Pyrazine Ligands for Neuronal Nicotinic Receptors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,163,769 | Antibacterial Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,188,104 | Anti-Infective Agents and Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,178,548 | Anti-Infective Agents and Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,383,658 | Isoxazole Based Neuronal Nicotinic Receptor Ligands and Methods of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,648,069 | 5-Substituted Indazoles as Kinase Inhibitors In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US 9,365,579 | Novel Tricyclic Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D731,171 | Template for a Prescription Medicine Container In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 33 more term ends in 2029 · Pro | |||||
10 of 43 patents shown. Soonest term end first, then patent number.
Pro members see all 43.
41 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.